LUNG NEUROENDOCRINE TUMOR
Clinical trials for LUNG NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new LUNG NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for LUNG NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control many different types of rare, advanced cancers that have limited treatment options. It enrolled over 800 adults whose cancer progressed after standard therapy. The g…
Matched conditions: LUNG NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 04:21 UTC
-
New hope for slowing advanced neuroendocrine tumors in Final-Stage trial
Disease control OngoingThis study is testing whether the drug cabozantinib can slow the growth of advanced neuroendocrine tumors better than a placebo in people whose cancer has continued to worsen despite prior treatments. About 298 participants with specific advanced neuroendocrine tumors will be ran…
Matched conditions: LUNG NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC